摘要 |
<p>The present invention provides a compound of formula I: (formula I) said compound is inhibitor of selective subset of kinases belonging to the AGC or calmodulin kinase family, such as for example MARK1/2/3, PKD-1/2/3, PKN-1/2, CDK-9, CaMKII, ROCK-I/II, inhibitors of histone deacetylase (HDAC) phosphorylation, or inhibitors of other kinases. Finally, the present invention also provides a pharmaceutical composition.</p> |
申请人 |
NOVARTIS AG;DOBLER, MARKUS ROLF;JEWELL, CHARLES FRANCIS JR;MEREDITH, ERIK;MONOVICH, LAUREN G.;SISKA, SARAH;VON MATT, ANETTE;VAN EIS, MAURICE;YOON, TAEYOUNG;GAUL, CHRISTOPH;CAPPARELLI, MICHAEL PAUL |
发明人 |
DOBLER, MARKUS ROLF;JEWELL, CHARLES FRANCIS JR;MEREDITH, ERIK;MONOVICH, LAUREN G.;SISKA, SARAH;VON MATT, ANETTE;VAN EIS, MAURICE;YOON, TAEYOUNG;GAUL, CHRISTOPH;CAPPARELLI, MICHAEL PAUL |